Alosetron to return to market.
Donna
D
Young
D002243:Carbolines / Q000008:administration & dosage* / Q000627:therapeutic use*; D003109:Colonic Diseases, Functional / Q000188:drug therapy; D017277:Drug Approval; D004348:Drug Labeling / Q000331:legislation & jurisprudence; D011307:Drug Prescriptions; D005765:Gastrointestinal Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D002243:Carbolines; D005765:Gastrointestinal Agents; C090840:alosetron